NewsRx

Search our medical news database

Aspreva Pharmaceuticals

Aspreva Sends Materials for Special Meeting to be Held December 17

Published in Healthcare Finance, Tax and Law Weekly, December 5th, 2007

Aspreva Pharmaceuticals Corporation (NASDAQ: ASPV; TSX: ASV) announced that meeting materials regarding a special meeting to consider the proposed statutory plan of arrangement ("Arrangement") with Galenica Group have been mailed to Aspreva shareholders and optionholders of record. Copies of the meeting materials, including the management information circular and forms of proxy, are available on the United States Securities and Exchange Commission's website at www.sec.gov, and on the Canadian provincial securities authorities SEDAR website at www.sedar.com.

As indicated in the management information circular mailed today, Aspreva's Board of Directors has approved the...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook